Chronic kidney disease is a slow, often silent condition in which the kidneys progressively lose their ability to filter waste from the blood. Because symptoms frequently do not appear until substantial function has been lost, researchers have long searched for early, readily measurable signals that identify people at risk before the damage becomes irreversible. Dyslipidemia—an abnormal level of lipids in the blood—is extremely common in patients who already have CKD, typically manifesting as elevated triglycerides, reduced high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels that are normal or only slightly raised. What has remained less clear is whether this distinctive dyslipidemic pattern precedes the onset of kidney disease and can therefore serve as a warning sign rather than simply a consequence.

To address that question, the research team, led by Dandan Li of the First Affiliated Hospital of Henan University of Science and Technology and colleagues at Huaihe Hospital of Henan University and collaborating institutions in China, analyzed data from adults aged 40 years and older whose baseline estimated glomerular filtration rate (eGFR)—the standard measure of kidney filtering capacity—exceeded 60 mL/min/1.73 m². The participants were followed for six years. The team examined eight lipid parameters: triglycerides (TG), total cholesterol (TC), HDL-C, LDL-C, the triglyceride-to-HDL-C ratio (TG/HDL-C), the total-cholesterol-to-HDL-C ratio (TC/HDL-C), the non-HDL-cholesterol-to-HDL-C ratio (NHHR), and residual cholesterol (RC), a measure of cholesterol carried in triglyceride-rich lipoprotein remnants that is increasingly studied for its role in cardiovascular disease.

The main outcome was carefully defined: incident CKD was recorded when a participant’s eGFR fell by at least 30 percent from its baseline value and finished the follow-up period below 60 mL/min/1.73 m². This dual criterion helps ensure that the classification captures a genuine, clinically meaningful decline in kidney function rather than ordinary measurement variability. Using multivariate logistic regression, the researchers adjusted for a range of potential confounders, including demographic factors and clinical covariates, and employed restricted cubic spline analyses to explore the shape of the relationships and subgroup analyses to test whether the associations differed across patient characteristics.

The results were striking in their consistency. Over the six years of follow-up, 453 of the 3,856 participants—11.7 percent of the cohort—developed incident CKD. After full statistical adjustment, participants in the highest tertile of log-transformed triglycerides had 59 percent higher odds of developing CKD compared with those in the lowest tertile, with an odds ratio of 1.59 and a 95 percent confidence interval of 1.24 to 2.05. Total cholesterol told a similar story, with an odds ratio of 1.49 (95 percent CI: 1.15 to 1.92) for the highest versus lowest tertile.

The composite indices performed at least as well as the conventional parameters. The TC/HDL-C ratio was associated with an odds ratio of 1.51 (95 percent CI: 1.17 to 1.95), while the TG/HDL-C ratio produced the largest effect estimate in the analysis, at 1.63 (95 percent CI: 1.26 to 2.10). The non-HDL-cholesterol-to-HDL-C ratio, a composite measure that captures the balance between atherogenic and protective cholesterol fractions, yielded an odds ratio of 1.51 (95 percent CI: 1.17 to 1.95), and residual cholesterol was associated with an odds ratio of 1.50 (95 percent CI: 1.18 to 1.92). In other words, every one of the pro-atherogenic lipid measures examined—whether conventional or composite—pointed in the same direction: higher levels corresponded to higher odds of future kidney disease.

There was one notable exception, and it was protective. Higher levels of HDL-C, often described as the “good” cholesterol because of its role in reverse cholesterol transport, were associated with lower odds of incident CKD, with an odds ratio of 0.75 (95 percent CI: 0.58 to 0.96). This inverse relationship fits mechanistically with HDL’s established anti-inflammatory and antioxidant functions, which some researchers believe may extend to protecting the delicate filtration structures of the kidney from lipid-mediated injury.

The subgroup analyses added an intriguing nuance. Most of the associations held steady across prespecified subgroups of participants, but the TG/HDL-C ratio showed a higher effect estimate in people without diabetes. This observation is scientifically interesting because diabetic kidney disease has its own well-characterized risk architecture; the suggestion that the triglyceride-HDL balance may be an especially informative predictor among non-diabetic adults raises the possibility that composite lipid indices could help identify kidney risk in a population where clinical vigilance is often lower. The authors also employed restricted cubic spline analysis, a flexible statistical technique that models non-linear dose-response relationships, to characterize how risk varied across the full range of lipid values rather than only at arbitrary cutoffs.

From a mechanistic standpoint, several pathways could link lipid disturbances to kidney damage. Elevated triglycerides and residual cholesterol reflect an abundance of triglyceride-rich lipoproteins and their remnants, particles that can deposit in tissues, provoke inflammation, and injure the glomeruli—the microscopic filtration units of the kidney. Lipid accumulation within kidney cells can trigger oxidative stress and fibrosis, processes that progressively scar renal tissue and erode filtering capacity. At the same time, the possibility of reverse causation cannot be fully dismissed in an observational, retrospective design: subtle early kidney dysfunction may itself alter lipid metabolism, and the study’s reliance on routinely collected clinical data means that unmeasured confounding remains a possibility. The authors note that the study received no external funding and was approved by the Clinical Research Ethics Committee of Huaihe Hospital, Henan University, which waived individual informed consent owing to the retrospective nature of the analysis.

The practical implications, however, are immediately relevant to everyday medicine. Lipid panels are among the most commonly ordered laboratory tests in the world, and the parameters highlighted in this study—triglycerides, HDL-C, and simple ratios derived from them—require no additional blood draws, no specialized equipment, and no added cost. If the findings are confirmed in prospective and ethnically diverse cohorts, clinicians could conceivably incorporate composite lipid indices into routine kidney risk stratification, flagging patients whose blood fat profiles warrant closer monitoring of eGFR and earlier intervention with lifestyle modification or lipid-lowering therapy. With chronic kidney disease affecting hundreds of millions of people globally and often progressing unnoticed until dialysis or transplantation becomes necessary, the idea that a number already printed on nearly every routine lab report might help predict who will lose kidney function is a compelling—and potentially consequential—step forward for preventive nephrology.

Subject of Research: The association between conventional and composite blood lipid parameters and the risk of developing incident chronic kidney disease in adults

Article Title: Lipid parameters and the risk of incident CKD: an analysis of conventional and composite lipid indices

Article References: Li, D., Song, Z., Wang, X., Xu, H., Li, X., Yan, S., Yu, T., Liu, Y., Liu, Z., & Jiang, H. (2026). Lipid parameters and the risk of incident CKD: an analysis of conventional and composite lipid indices. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02529-y

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02529-y

Keywords: chronic kidney disease, triglycerides, HDL cholesterol, LDL cholesterol, lipid ratios, residual cholesterol, dyslipidemia, eGFR, cohort study, nephrology, cardiovascular risk, kidney disease prevention